Publications in collaboration with researchers from Clínica Universitaria de Navarra (1)

2025

  1. FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease

    Molecular Therapy, Vol. 33, Núm. 3, pp. 895-916